市場調査レポート

院内感染症検査 (肺炎・UTI・血流感染・手術部位感染・MRSA感染・その他) の世界の産業分析・市場規模・市場シェア・成長率・市場動向・市場予測 (2015 - 2023年)

Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

発行 Transparency Market Research 商品コード 294640
出版日 ページ情報 英文 85 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
院内感染症検査 (肺炎・UTI・血流感染・手術部位感染・MRSA感染・その他) の世界の産業分析・市場規模・市場シェア・成長率・市場動向・市場予測 (2015 - 2023年) Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
出版日: 2015年12月24日 ページ情報: 英文 85 Pages
概要

当レポートでは、世界の院内感染症検査市場について調査し、市場成長への各種影響因子および市場機会の分析、検査区分・地域/主要国別の収益規模の推移と予測、提言、主要企業のプロファイルなどをまとめています。

第1章 序論

第2章 エグゼクティブサマリー

  • 世界の院内感染症検査市場の地域別シェアの予測
  • 世界の院内感染症検査市場の実績:検査区分別
  • 院内感染症検査市場の概要

第3章 院内感染症検査市場:産業分析

  • イントロダクション
  • 市場成長推進因子
    • 政府によるガイドライン・医療関連感染 (HAI) 防止規約の確立
    • HAIの発症率の拡大と薬物耐性病原菌の増加
  • 市場成長阻害因子
    • 厳しい法規制・ガイダンスの枠組み
    • 途上国における統制機関・統制プログラムの欠如
  • 市場機会
    • 米国「Patient Care and Affordable Care Act」
    • 分子診断分野における技術的発展
  • ポーターのファイブフォース分析
  • 市場の魅力度分析:地域別

第4章 市場分析:検査区分別

  • イントロダクション
  • 世界の院内感染症検査市場の収益予測:検査区分別
    • 尿路感染症検査
    • 手術部位感染検査
    • 肺炎感染検査
    • 血流感染症検査
    • その他の感染症検査

第5章 地域分析

  • イントロダクション
  • 世界の院内感染症検査市場の収益予測:地域別
  • 北米市場の収益予測:国別
  • 北米市場の収益予測:検査区分別
  • 欧州市場の収益予測:国別
  • 欧州市場の収益予測:検査区分別
  • アジア太平洋市場の収益予測:国別
  • アジア太平洋市場の収益予測:検査区分別
  • ラテンアメリカ市場の収益予測:国別
  • ラテンアメリカ市場の収益予測:検査区分別
  • 中東・アフリカ市場の収益予測:国別
  • 中東・アフリカ市場の収益予測:検査区分別

第6章 提言

第7章 企業プロファイル

  • Abbott Laboratories
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • QIAGEN
  • Siemens Healthcare
  • Diatherix Laboratories, Inc.
  • Meridian Bioscience, Inc.
  • Thermo Fisher Scientific, Inc.(Life Technologies Corporation)
  • Cepheid, Inc.

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

This report covers the market analysis for various diagnostic tests performed to detect hospital associated infections, also called as nosocomial infections. Morbidity rate of nosocomial infections is increasing rapidly worldwide, thereby driving the hospital associated infection(HAI) diagnostic market towards remarkable growth. The stakeholders for this study include manufacturers and providers of diagnostic solutions for nosocomial infections.

The global hospital acquired disease testing market is categorized on the basis of test types, i.e., urinary tract infection, surgical site infection, pneumonia, blood stream infection, MRSA infection, and others. A detailed market analysis and forecast for these segments has been provided in this study, in terms of market revenue(US$ Mn) for the period 2013 to 2023. The report also provides with the compounded annual growth rate(CAGR %) for each infection type for the forecast period 2015 to 2023, while market size estimations have been made considering 2014 as the base year.

In terms of geographical distribution, the global hospital acquired disease testing market has been classified into four geographical areas: North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The current and future market sizes(in terms of US$ Mn) of the above regional markets have been provided in the report for the period 2013 to 2023 with their growth rate(%) for the period 2015 to 2023. The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and grow in the global hospital acquired disease testing market.

The market overview section of the report demonstrates the market dynamics and market trends such as the drivers, restraints and opportunities that influence the current nature and future status of this field. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global hospital acquired disease testing market.

This report concludes with the company profiles section which includes key information about the major players in this market. Some of the key players profiled in this report include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche, Cepheid, Inc., Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.

The global hospital acquired disease testing market is segmented as follows:

Global Hospital Acquired Disease Testing Market, by Test

  • Pneumonia infection
  • Urinary tract infection
  • Blood stream associated infection
  • Surgical site infection
  • MRSA infection
  • Others

Global Hospital Acquired Disease Testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest pf APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents

Chapter 1 - Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

Chapter 2 - Executive Summary

  • 2.1. Global Hospital Acquired Disease Testing Market Share, by Geography, 2014-2023(US$ Mn)
  • 2.2. Global Hospital Acquired Disease Testing Market, by Test, 2014(US$ Mn)
  • 2.3. Hospital Acquired Disease Testing Market Snapshot

Chapter 3 - Hospital Acquired Disease Testing Market - Industry Analysis

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Establishment of government guidelines and code for prevention of HAIs
    • 3.2.2. Increase in prevalence of HAIs and rise in the number of drug resistant pathogens
  • 3.3. Restraints
    • 3.3.1. Stringent regulations and guidance framework
    • 3.3.2. Lack of controlling authorities and control programs in less developed regions
  • 3.4. Opportunity
    • 3.4.1. Passage of the Patient Care and Affordable Care Act in the U.S.
    • 3.4.2. Technological development in the field of molecular diagnostics
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis- Hospital Acquired Disease Testing Market, by Geography(2014)(Value %)

Chapter 4 - Market Segmentation - By Test

  • 4.1. Introduction
  • 4.2. Global Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)
    • 4.2.1. Global Urinary Tract Infection Testing Market Revenue, 2013-2023(US$ Mn)
    • 4.2.2. Global Surgical Site Infection Testing Market Revenue, 2013-2023(US$ Mn)
    • 4.2.3. Global Pneumonia Infection Testing Market Revenue, 2013-2023(US$ Mn)
    • 4.2.4. Global Bloodstream Infection Testing Market Revenue, 2013-2023(US$ Mn)
    • 4.2.5. Global Others Infection Testing Market Revenue, 2013-2023(US$ Mn)

Chapter 5 - Market Segmentation - By Geography

  • 5.1. Introduction
  • 5.2. Global Hospital Acquired Disease Testing Market Revenue, by Geography, 2013-2023(US$ Mn)
  • 5.3. North America Hospital Acquired Disease Testing Market Revenue, by Country, 2013-2023(US$ Mn)
  • 5.4. North America Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)
  • 5.5. Europe Hospital Acquired Disease Testing Market Revenue, by Country, 2013-2023(US$ Mn)
  • 5.6. Europe Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)
  • 5.7. Asia Pacific Hospital Acquired Disease Testing Market Revenue, by Country, 2013-2023(US$ Mn)
  • 5.8. Asia Pacific Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)
  • 5.9. Latin America Hospital Acquired Disease Testing Market Revenue, by Country, 2013-2023(US$ Mn)
  • 5.10. Latin America Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)
  • 5.11. Middle East & Africa Hospital Acquired Disease Testing Market Revenue, by Country, 2013-2023(US$ Mn)
  • 5.12. Middle East & Africa Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)

Chapter 6 - Recommendations

Chapter 7 - Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. Alere, Inc.
  • 7.3. Becton, Dickinson and Company
  • 7.4. bioMérieux SA
  • 7.5. F. Hoffmann-La Roche Ltd.
  • 7.6. Hologic, Inc.
  • 7.7. QIAGEN
  • 7.8. Siemens Healthcare
  • 7.9. Diatherix Laboratories, Inc.
  • 7.10. Meridian Bioscience, Inc.
  • 7.11. Thermo Fisher Scientific, Inc.(Life Technologies Corporation)
  • 7.12. Cepheid, Inc.
Back to Top